ANDA 62784, held by Quad Pharms. Lincomycin Hydrochloride.
As of Nov 15, 2026, ANDA 62784 (Lincomycin Hcl), held by Quad Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Lincomycin HclEQ 300MG BASE/ML ยท injectable; injection | Lincomycin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
